Growth Metrics

Marsh & Mclennan Companies (MRSH) EBIAT (2016 - 2026)

Marsh & Mclennan Companies filings provide 18 years of EBIAT readings, the most recent being $1.1 billion for Q1 2026.

  • On a quarterly basis, EBIAT fell 18.84% to $1.1 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $3.9 billion, a 4.97% decrease, with the full-year FY2025 number at $4.2 billion, up 2.84% from a year prior.
  • EBIAT reached $1.1 billion in Q1 2026 per MRSH's latest filing, up from $834.0 million in the prior quarter.
  • The five-year high for EBIAT was $1.4 billion in Q1 2024, with the low at $503.0 million in Q4 2022.
  • A 5-year average of $965.1 million and a median of $967.0 million in 2022 define the central range for EBIAT.
  • Year-over-year, EBIAT crashed 35.18% in 2022 and then skyrocketed 50.3% in 2023.
  • Year by year, EBIAT stood at $503.0 million in 2022, then skyrocketed by 50.3% to $756.0 million in 2023, then grew by 11.77% to $845.0 million in 2024, then fell by 1.3% to $834.0 million in 2025, then surged by 37.41% to $1.1 billion in 2026.
  • Per Business Quant, the three most recent readings for MRSH's EBIAT are $1.1 billion (Q1 2026), $834.0 million (Q4 2025), and $747.0 million (Q3 2025).